Claims for Patent: 6,933,310

Summary for Patent: 6,933,310

Title:	Therapeutic agent for amyotrophic lateral sclerosis (ALS)
Abstract:	An object of the present invention is to provide a novel medicament with which motor neuron diseases can be treated. According to the present invention, there is provided a therapeutic agent for motor neuron diseases which comprises 3-methyl-1-phenyl-2-pirazoline-5-on or physiologically acceptable salts thereof as an active ingredient.
Inventor(s):	Ikeda; Ken (Tokyo, JP)
Assignee:	Mitsubishi Pharma Corporation (Osaka, JP)
Application Number:	10/399,961
Patent Claims:	1. A method for treating motor neuron diseases consisting essentially of administering an effective amount of 3-methyl-1-phenyl-2-pyrazoline-5-one or a physiologically acceptable salt thereof to a patient. 2. The treatment method according to claim 1 wherein the progress of motor neuron diseases is delayed. 3. The treatment method according to claim 1 wherein the motor neuron disease is amyotrophic lateral sclerosis (ALS), spinal muscle atrophy (SMA), progressive bulbar palsy, or primary lateral sclerosis (PLS). 4. The treatment method according to claim 1 wherein the motor neuron disease is amyotrophic lateral sclerosis (ALS). 5. A method for enhancing motor neurons consisting essentially of administering an effective amount of 3-methyl-1-phenyl-2-pyrazoline-5-one or a physiologically acceptable salt thereof to a patient.